Results 211 to 220 of about 101,301 (311)

Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities—A cross‐sectional study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study was conducted to investigate the association between migraine frequency and insomnia severity. Background Migraine and insomnia frequently co‐occur, yet the relationship between migraine characteristics and insomnia severity remains poorly understood.
Kuang‐Heng Lee, Chih‐Sung Liang, Po‐Kuan Yeh, Chia‐Kuang Tsai, Chia‐Lin Tsai, Yu‐Kai Lin, Guan‐Yu Lin, Ming‐Chen Tsai, Yi Liu, Yuan‐Zhen Ruan, Fu‐Chi Yang   +10 more
wiley   +1 more source

The impact of CGRP monoclonal antibodies on cytokine expression in chronic migraine: a cohort study. [PDF]

J Neurol
Ray JC, McDonald S, Todaro M, Baker J, Yeh WZ, Hutton EJ, Matharu M, Butzkueven H.   +7 more
europepmc   +1 more source

CD200/CD200R1 alleviates central sensitization in a chronic migraine model by promoting STAT6 phosphorylation and modulating microglial M2 polarization

Zhaoming
openalex   +1 more source

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary This study shows that galcanezumab is equally effective and well‐tolerated in patients aged 65 and older as in younger patients, with a higher proportion of excellent responders in older patients. Despite having more baseline headache days, older patients responded well to the treatment, with age being linked to better outcomes ...
Julia Peris‐Subiza, Víctor Obach, Daniel Guisado‐Alonso, Fernando Velasco Juanes, Rocío Álvarez Escudero, María Martín Bujanda, Sonsoles Aranceta, Aintzine Ruisánchez, Natalia Roncero, Ane Mínguez‐Olaondo, Amaya Echeverria, Alba López‐Bravo, Ángel Luis Guerrero‐Peral, David García‐Azorín, Elisa Cuadrado‐Godia, Galca‐Only Study Group, Neus Fabregat, Marta Ruibal, Izaro Kortazar Zubizarreta, Nuria Riesco, Lucia González‐Fernández, Paula Manera, Agustín Oterino Duran, Yésica González‐Osorio, Santiago Fernández‐Fernández, Juan Carlos García‐Moncó, Isabel Fernández‐Pérez, Joan Jiménez‐Balado   +27 more
wiley   +1 more source

Analytical cross-sectional study on lifestyle factors associated with chronic migraine frequency. [PDF]

Bioinformation
Kalsariya SR, Palaniappan A, Saoji A, I S Kumar S, Relhan J.   +4 more
europepmc   +1 more source

ANALGESIC PHARMACOTHERAPY IN DYSMENORRHEA AND THE RISK OF DEVELOPING CHRONIC MIGRAINE

Karolina Wojdat-Krupa, Weronika Ossowska, Filip Lachowski, Karol Sikora, Julia Dolinkiewicz, Martyna Wasyluk   +5 more
openalex   +2 more sources

Erratum to: Greater occipital nerve block in chronic migraine [PDF]

, 2011
Maria Gabriella Saracco, Walter Valfrè, Marco Cavallini, Marco Aguggia   +3 more
openalex   +1 more source

Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective The current study aimed to evaluate the remote electrical neuromodulation (REN) wearable device over 3 years, assessing the potential for tachyphylaxis, consistent effectiveness, overall utilization patterns, and safety. Background Migraine is a highly prevalent chronic neurological disease, especially during peak years of ...
Stephanie J. Nahas, Marius Birlea, Alit Stark‐Inbar, Sharon Shmuely, Eden Mama, Alon Ironi, William B. Young, Alan M. Rapoport   +7 more
wiley   +1 more source

Chronic invasive fungal rhinosinusitis in a patient with chronic migraine. [PDF]

IDCases
Sun M, Liu Y.
europepmc   +1 more source

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To evaluate the effect of erenumab treatment beyond monthly migraine days in patients with high‐frequency episodic migraine who did not respond to at least one previous migraine preventive treatment. Background Reduction in monthly migraine days has been the efficacy standard for migraine preventive treatments; however, it does not ...
Gabriel Paiva da Silva Lima, Renata Rao, Gyöngyi Szabó, Sebastian Szklener, Cristina Tassorelli, Marcin Nastaj, Denise E. Chou, Ani C. Khodavirdi, Mahan Chehrenama, Yineng Zhu, Ajay K. Bhatia, David W. Dodick   +11 more
wiley   +1 more source